Back
Results - Announcements
Sales rise 2.69% to Rs 84.08 crore
Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
28-May-2026, 07:23
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.
For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 84.08 | 81.88 | 3 | 311.66 | 303.08 | 3 |
| OPM % | 12.57 | 9.33 | - | 10.24 | 9.75 | - |
| PBDT | 6.28 | 4.77 | 32 | 17.01 | 14.91 | 14 |
| PBT | 3.22 | 2.59 | 24 | 5.93 | 5.14 | 15 |
| NP | 3.59 | 5.43 | -34 | 6.28 | 7.22 | -13 |
Powered by Capital Market - Live News